Replies to post #3672 on Marker Therapeutics Inc (MRKR)

[Jukimol]

TPIV has an amazing technology that may be the key to solving Breast and Ovarian cancer. As you can see on the chart, people are starting to discover the stock (volume increasing in the last few weeks), so as people become aware of the technology, the stock will continue to attract new buyers.

more:

http://www.stockhouse.com/news/press-releases/2014/11/03/the-most-undervalued-yet-comprehensive-cancer-immunotherapy-in-development